Drug Type Small molecule drug |
Synonyms Ridrone Plus, Risen Plus, Risenex M + [1] |
Target |
Action inhibitors, agonists |
Mechanism FDPS inhibitors(Farnesyl diphosphate synthase inhibitors), VDR agonists(Vitamin D receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (23 Jun 2010), |
Regulation- |
Molecular FormulaC27H44O |
InChIKeyQYSXJUFSXHHAJI-YRZJJWOYSA-N |
CAS Registry67-97-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteoporosis | South Korea | 23 Jun 2010 |